The Cochrane Metabolic and Endocrine Disorders Review Group and its possible impact on the Spanish Society of DiabetesSeminars of diabetes
- Vol.25 N.5 setember-october 2009B. Richter1, D. Mauricio2
Evidence based medicine means the integration of the best research evidence
with clinical expertise and the patient’s unique values and circumstances. Today,
nobody seriously questions this concept anymore but strong counterforces
try to distort or circumvent this momentum. The Cochrane Collaboration
is one of the very few independent organisations of considerable size in medicine
trying to establish high-quality systematic reviews and publish these in
The Cochrane Library. The Cochrane Metabolic and Endocrine Disorders Group
(CMED), one of more than 50 Cochrane Review Groups focuses on systematic
reviews of the benefits and harms of healthcare interventions for metabolic
and endocrine disorders. A Cochrane review is a formidable challenge but
help is provided through all stages of review production by the CMED. More
than 500 authors are currently actively participating in our group and helped
to create the present impact factor of 5.182. Increased input to Cochrane reviews
from a wider range of cultural and socio-economic sectors such as the
‘Hispano side of the world’ would be welcome to provide better information to
Correspondencia: Prof. Dr. Bernd Richter, MD, PhD. Coordinating Editor.
Cochrane Metabolic and Endocrine Disorders Review Group. Department of General Practice.
University Hospital Duesseldorf. Heinrich-Heine University. Postfach 10 10 07. D-40001 Duesseldorf.
Keywordsdiabetes mellitus Netting the evidence (EBM) meta-analysis, , Cochrane Review systematic reviews